CT Virtual Proctoscopy for Staging and Volume Assessment for Rectal Cancer
4 other identifiers
interventional
20
1 country
1
Brief Summary
The purpose of this study is to see how CT virtual proctoscopy compares to an ultrasound exam of the rectal area in determining the stage of rectal cancer for people recently diagnosed with rectal cancer. This study will also compare tumor volume before and after neoadjuvant therapy using CT virtual proctoscopy, with the ultrasound exam as a comparison. Neoadjuvant therapy consists of chemotherapy and radiation therapy. Neoadjuvant chemoradiation therapy is done before surgery to reduce the size of tumors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 21, 2007
CompletedFirst Posted
Study publicly available on registry
January 3, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedDecember 13, 2019
August 1, 2011
3.9 years
December 21, 2007
December 12, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
The utility of CT virtual proctoscopy (CTVP) for evaluation of rectal cancer.
3 months
Study Arms (1)
1
OTHERCT virtual proctoscopy
Interventions
CTVP done prior to initiation of therapy and a couple of weeks before patient has surgery.
Eligibility Criteria
You may qualify if:
- Patients who have been diagnosed with adenocarcinoma of the rectum, who have not started their neoadjuvant treatment yet.
You may not qualify if:
- Patients who have started their neoadjuvant therapy already
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin Hospital & Clinics
Madison, Wisconsin, 53792, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles P Heise, M.D.
UW Hospital & Clinics, Department of Surgery
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2007
First Posted
January 3, 2008
Study Start
September 1, 2007
Primary Completion
August 1, 2011
Study Completion
August 1, 2011
Last Updated
December 13, 2019
Record last verified: 2011-08